The Hidden Cost Of Schizophrenia
/* 468x60, */
People being treated for schizophrenia are more likely than the general population to have encounters with the criminal justice system in the US. A study published in the open access journal BMC Psychiatry has shown that schizophrenia patients' involvement with the criminal justice system is primarily driven by their being victims of crime and that the average annual per-patient cost of involvement with the criminal justice system was $1429.
Haya Ascher-Svanum led a team of researchers from Eli Lilly and Company, USA, who used data from a study of around 600 people with schizophrenia to estimate the prevalence and cost of involvement with the criminal justice system. They found that 46% had had at least one encounter, and these patients were more likely to be younger, with poorer mental health, and less likely to adhere to their medication regime. Being a crime victim was the most prevalent type of encounter, comprising 67% of these patients.
The team also estimated, for the first time, the direct economic impact of legal involvement. According to Ascher-Svanum, "These encounters may comprise approximately 6% to 11% of the annual per-patient direct total costs. When assessing the costs of schizophrenia, future studies should account for potential criminal justice system involvement whenever possible".
Involvement in the US criminal justice system and cost implications for persons treated for schizophrenia
Haya Ascher-Svanum, Allen W. Nyhuis, Douglas E. Faries, Daniel E. Ball and Bruce J. Kinon
BMC Psychiatry (in press)
Article available at journal website: http://www.biomedcentral.com/bmcpsychiatry/
Source: Graeme Baldwin
/* 468x60, */
Last relative articles:
- The Prevention Of Psychiatric Patient Suicides
- Fish Oil May Reduced Risk Of Psychotic Disorders In High Risk Individuals
- Early Intervention Could Prevent Schizophrenia
- Identification Of Brain Protein For Synapse Development
- Childhood Clues To Adult Schizophrenia
- Duke To Lead Effort To Better Understand The Role Of Rare Genetic Variation In Clozapine-induced Agranulocytosis Using Whole Genome Sequencing
- Launch Of Largest Academic-Industry Collaboration For Drug Discovery In Depression And Schizophrenia
- Blood Test For Schizophrenia Could Be Ready This Year
- Examining The Impact Of FDA Safety Warnings
- A Flying Boost For Neuroscience
schizophrenia, cost schizophrenia, schizophrenia hidden, treated schizophrenia, schizophrenia patients, schizophrenia people, schizophrenia likely, schizophrenia estimate, schizophrenia future, psychiatry schizophrenia